54 research outputs found

    \u3ci\u3eLiomys irroratus\u3c/i\u3e

    Get PDF
    Liomys Merriam, 1902 Spiny Pocket Mice Liomys Merriam, 1902:44. Type species Heteromys alleni Coues (=Liomys irroratus alleni). Context and Content: Order Rodentia, Family Heteromyidae, Subfamily Heteromyinae. The genus Liomys contains five known species

    Liomys irroratus

    Get PDF
    Liomys Merriam, 1902 Spiny Pocket Mice Liomys Merriam, 1902:44. Type species Heteromys alleni Coues (=Liomys irroratus alleni). CONTEXT AND CONTENT: Order Rodentia, Family Heteromyidae, Subfamily Heteromyinae. The genus Liomys contains five known species

    Bats of the Devils River State Natural Area- Big Satan Unit, Val Verde County, Texas

    Get PDF
    A survey of bats is being conducted to determine the species diversity and community composition at Devils River State Natural Area (DRSNA) – Big Satan Unit, as part of ongoing research with the Texas Parks and Wildlife Department. The DRSNA is a 38,000-acre preserve situated along a 10.8-mile stretch of the Devils River in Val Verde County, 40 miles north of Del Rio, Texas. A handheld acoustic monitoring device, the Echo Meter EM3+ Ultrasonic Recorder, was used to detect species based on echolocation calls. Calls were recorded along an 8-mile long transect route that runs generally west to east across DRSNA, and at three stationary netting sites around the survey area. Echolocation calls vary among bats allowing species to be identified in flight. An analysis software system, called Kaleidoscope, was used to analyze the sound files recorded. Kaleidoscope is an integrated suite of bat data tools designed to help quickly convert files, and sort and categorize bat data by species. From a total of 3,845 sound files recorded so far, 699 have been recognized as good bat echolocation calls that can be used to identify species, while 3,146 were eliminated as noise files. Preliminary results found seven species (Lasiurus borealis, Lasiurus cinereus, Lasionycteris noctivagans, Nycticeius humeralis, Parastrellus hesperus, Perimyotis subflavus, Tadarida brasiliensis) present at DRSNA. We will continue to collect data for the next year and hope to predict bat species distributions, map centers of high diversity, and identify key conservation areas at Devils River.Graduate Student Research Fellowshi

    Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

    Get PDF
    Contains fulltext : 79496.pdf (publisher's version ) (Open Access)BACKGROUND: This Phase 1/2a study evaluated the safety, immunogenicity, and efficacy of an experimental malaria vaccine comprised of the recombinant Plasmodium falciparum protein apical membrane antigen-1 (AMA-1) representing the 3D7 allele formulated with either the AS01B or AS02A Adjuvant Systems. METHODOLOGY/PRINCIPAL FINDINGS: After a preliminary safety evaluation of low dose AMA-1/AS01B (10 microg/0.5 mL) in 5 adults, 30 malaria-naive adults were randomly allocated to receive full dose (50 microg/0.5 mL) of AMA-1/AS01B (n = 15) or AMA-1/AS02A (n = 15), followed by a malaria challenge. All vaccinations were administered intramuscularly on a 0-, 1-, 2-month schedule. All volunteers experienced transient injection site erythema, swelling and pain. Two weeks post-third vaccination, anti-AMA-1 Geometric Mean Antibody Concentrations (GMCs) with 95% Confidence Intervals (CIs) were high: low dose AMA-1/AS01B 196 microg/mL (103-371 microg/mL), full dose AMA-1/AS01B 279 microg/mL (210-369 microg/mL) and full dose AMA-1/AS02A 216 microg/mL (169-276 microg/mL) with no significant difference among the 3 groups. The three vaccine formulations elicited equivalent functional antibody responses, as measured by growth inhibition assay (GIA), against homologous but not against heterologous (FVO) parasites as well as demonstrable interferon-gamma (IFN-gamma) responses. To assess efficacy, volunteers were challenged with P. falciparum-infected mosquitoes, and all became parasitemic, with no significant difference in the prepatent period by either light microscopy or quantitative polymerase chain reaction (qPCR). However, a small but significant reduction of parasitemia in the AMA-1/AS02A group was seen with a statistical model employing qPCR measurements. SIGNIFICANCE: All three vaccine formulations were found to be safe and highly immunogenic. These immune responses did not translate into significant vaccine efficacy in malaria-naive adults employing a primary sporozoite challenge model, but encouragingly, estimation of parasite growth rates from qPCR data may suggest a partial biological effect of the vaccine. Further evaluation of the immunogenicity and efficacy of the AMA-1/AS02A formulation is ongoing in a malaria-experienced pediatric population in Mali. TRIAL REGISTRATION: www.clinicaltrials.gov NCT00385047

    Mammal collections of the Western Hemisphere: A survey and directory of collections

    Get PDF
    As a periodic assessment of the mammal collection resource, the Systematic Collections Committee (SCC) of the American Society of Mammalogists undertakes decadal surveys of the collections held in the Western Hemisphere. The SCC surveyed 429 collections and compiled a directory of 395 active collections containing 5,275,155 catalogued specimens. Over the past decade, 43 collections have been lost or transferred and 38 new or unsurveyed collections were added. Growth in number of total specimens, expansion of genomic resource collections, and substantial gains in digitization and web accessibility were documented, as well as slight shifts in proportional representation of taxonomic groups owing to increasingly balanced geographic representation of collections relative to previous surveys. While we find the overall health of Western Hemisphere collections to be adequate in some areas, gaps in spatial and temporal coverage and clear threats to long-term growth and vitality of these resources have also been identified. Major expansion of the collective mammal collection resource along with a recommitment to appropriate levels of funding will be required to meet the challenges ahead for mammalogists and other users, and to ensure samples are broad and varied enough that unanticipated future needs can be powerfully addressed. © 2018 The Author(s)
    corecore